Clearview Medical Research is categorized under Medical Research in Sherman Oaks, CA and active since 2012.
Clearview Medical Research was established in 2012, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Marina Gold at the company’s single location by writing to 13205 Rverside Drive Apartment 305, Sherman Oaks, California CA 91423 or by phoning (323) 633-4730. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Clearview Medical Research |
Contact Person: | Marina Gold |
Address: | 13205 Rverside Drive Apartment 305, Sherman Oaks, California 91423 |
Phone Number: | (323) 633-4730 |
Website Address: | clearviewmrc.com |
Annual Revenue (USD): | $0 to $49.999 |
Founded: | 2012 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Medical Research |
SIC Code: | 8733 |
NAICS Code: | 541720 |
Share This Business: |
Clearview Medical Research was started in 2012 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact Marina Gold for inquiries that concern Clearview Medical Research by calling the company number (323) 633-4730, as your correspondence is most welcome. Additionally, the physical location of the single location of Clearview Medical Research can be found at the coordinates 34.157758,-118.420483 as well as the street address 13205 Rverside Drive Apartment 305 in Sherman Oaks, California 91423.
For its online presence, you may visit Clearview Medical Research’s website at clearviewmrc.com and engage with its social media outlets through on Twitter and on Facebook.